BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

457 related articles for article (PubMed ID: 15505132)

  • 1. Metabolic significance of nonalcoholic fatty liver disease in nonobese, nondiabetic adults.
    Kim HJ; Kim HJ; Lee KE; Kim DJ; Kim SK; Ahn CW; Lim SK; Kim KR; Lee HC; Huh KB; Cha BS
    Arch Intern Med; 2004 Oct; 164(19):2169-75. PubMed ID: 15505132
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Relationships between estimates of adiposity, insulin resistance, and nonalcoholic fatty liver disease in a large group of nondiabetic Korean adults.
    Sung KC; Ryan MC; Kim BS; Cho YK; Kim BI; Reaven GM
    Diabetes Care; 2007 Aug; 30(8):2113-8. PubMed ID: 17475935
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nonalcoholic fatty liver disease in HIV-infected patients referred to a metabolic clinic: prevalence, characteristics, and predictors.
    Guaraldi G; Squillace N; Stentarelli C; Orlando G; D'Amico R; Ligabue G; Fiocchi F; Zona S; Loria P; Esposito R; Palella F
    Clin Infect Dis; 2008 Jul; 47(2):250-7. PubMed ID: 18532884
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Prevalence and associated risk factors of non-alcoholic fatty liver disease in hospitalized patients.
    Radu C; Grigorescu M; Crisan D; Lupsor M; Constantin D; Dina L
    J Gastrointestin Liver Dis; 2008 Sep; 17(3):255-60. PubMed ID: 18836616
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Should nonalcoholic fatty liver disease be included in the definition of metabolic syndrome? A cross-sectional comparison with Adult Treatment Panel III criteria in nonobese nondiabetic subjects.
    Musso G; Gambino R; Bo S; Uberti B; Biroli G; Pagano G; Cassader M
    Diabetes Care; 2008 Mar; 31(3):562-8. PubMed ID: 18056890
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [The prevalence of non-alcoholic fatty liver disease and its related risk factors in 1180 school children in Shanghai].
    Wan YP; Xu RY; Fang H; Lu LP; Zhang XM; Cai W
    Zhonghua Gan Zang Bing Za Zhi; 2007 Sep; 15(9):644-8. PubMed ID: 17903363
    [TBL] [Abstract][Full Text] [Related]  

  • 7. High prevalence of coronary heart disease in type 2 diabetic patients with non-alcoholic fatty liver disease.
    Lu H; Zeng L; Liang B; Shu X; Xie D
    Arch Med Res; 2009 Oct; 40(7):571-5. PubMed ID: 20082871
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Risk factors associated with nonalcoholic fatty liver disease and its relationship with the hepatic histological changes.
    Rodríguez-Hernández H; Gonzalez JL; Márquez-Ramirez MD; Flores-Hernandez M; Rodríguez-Morán M; Guerrero-Romero F
    Eur J Gastroenterol Hepatol; 2008 May; 20(5):399-403. PubMed ID: 18403941
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of nonalcoholic fatty liver disease on the development of metabolic disorders.
    Fan JG; Li F; Cai XB; Peng YD; Ao QH; Gao Y
    J Gastroenterol Hepatol; 2007 Jul; 22(7):1086-91. PubMed ID: 17608855
    [TBL] [Abstract][Full Text] [Related]  

  • 10. What are the risk factors and settings for non-alcoholic fatty liver disease in Asia-Pacific?
    Fan JG; Saibara T; Chitturi S; Kim BI; Sung JJ; Chutaputti A;
    J Gastroenterol Hepatol; 2007 Jun; 22(6):794-800. PubMed ID: 17498218
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Prevalence of and risk factors for nonalcoholic fatty liver disease: the Dionysos nutrition and liver study.
    Bedogni G; Miglioli L; Masutti F; Tiribelli C; Marchesini G; Bellentani S
    Hepatology; 2005 Jul; 42(1):44-52. PubMed ID: 15895401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Epidemiological survey of prevalence of fatty liver and its risk factors in a general adult population of Shanghai].
    Fang JG; Zhu J; Li XJ; Li R; Dai F; Song XM; Chen L; Li F; Chen SY
    Zhonghua Gan Zang Bing Za Zhi; 2005 Feb; 13(2):83-8. PubMed ID: 15727689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Association of cardiorespiratory fitness, body mass index, and waist circumference to nonalcoholic fatty liver disease.
    Church TS; Kuk JL; Ross R; Priest EL; Biltoft E; Blair SN
    Gastroenterology; 2006 Jun; 130(7):2023-30. PubMed ID: 16762625
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Nonalcoholic fatty liver, steatohepatitis, and the metabolic syndrome.
    Marchesini G; Bugianesi E; Forlani G; Cerrelli F; Lenzi M; Manini R; Natale S; Vanni E; Villanova N; Melchionda N; Rizzetto M
    Hepatology; 2003 Apr; 37(4):917-23. PubMed ID: 12668987
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevalence and risk factors of nonalcoholic fatty liver disease in an adult population of taiwan: metabolic significance of nonalcoholic fatty liver disease in nonobese adults.
    Chen CH; Huang MH; Yang JC; Nien CK; Yang CC; Yeh YH; Yueh SK
    J Clin Gastroenterol; 2006 Sep; 40(8):745-52. PubMed ID: 16940890
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Relationship of liver fat content to insulin resistance and metabolic syndrome].
    Yan HM; Gao X; Liu M; Gu Q; Zhang B; Li X
    Zhonghua Yi Xue Za Zhi; 2008 May; 88(18):1255-8. PubMed ID: 18844098
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Effect of body weight mass and its change on the incidence of nonalcoholic fatty liver disease].
    Fan JG; Zhou Q; Wo QH
    Zhonghua Gan Zang Bing Za Zhi; 2010 Sep; 18(9):676-9. PubMed ID: 20943079
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Nonalcoholic fatty liver disease in severely obese subjects.
    Gholam PM; Flancbaum L; Machan JT; Charney DA; Kotler DP
    Am J Gastroenterol; 2007 Feb; 102(2):399-408. PubMed ID: 17311652
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Associations between liver histology and cortisol secretion in subjects with nonalcoholic fatty liver disease.
    Targher G; Bertolini L; Rodella S; Zoppini G; Zenari L; Falezza G
    Clin Endocrinol (Oxf); 2006 Mar; 64(3):337-41. PubMed ID: 16487446
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prevalence of non-alcoholic fatty liver disease and its association with impaired glucose metabolism in Japanese adults.
    Jimba S; Nakagami T; Takahashi M; Wakamatsu T; Hirota Y; Iwamoto Y; Wasada T
    Diabet Med; 2005 Sep; 22(9):1141-5. PubMed ID: 16108839
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 23.